Finsterer J

Idioma: Ingles.
Referencias bibliográficas: 12
Paginas: 100-103
Archivo PDF: 35.68 Kb.

FRAGMENTO

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Zeviani M. Mitochondrial disorders. Suppl Clin Neurophysiol 2004; 57: 304-12.

2. Zaffanello M, Zamboni G. Therapeutic approach in a case of Pearson’s syndrome. Minerva Pediatr 2005; 57: 143-6.

3. Inbal A, Avissar N, Shaklai M, Kuritzky A, Schejter A, Ben-David E, Shanske S, Garty BZ. Myopathy, lactic acidosis, and sideroblastic anemia: a new syndrome. Am J Med Genet 1995; 55: 372-8.

4. Muraki K, Nishimura S, Goto Y, Nonaka I, Sakura N, Ueda K. The association between haematological manifestation and mtDNA deletions in Pearson syndrome. J Inherit Metab Dis 1997; 20: 697-703.

5. Reichenbach J, Schubert R, Horvŕth R, Petersen J, Fütterer N, Malle E, Stumpf A, et al. Fatal neonatal-onset mitochondrial respiratory chain disease with T cell immunodeficiency. Pediatr Res 2006; 60: 321-6.

6. Espinosa G, Bucciarelli S, Cervera R, Lozano M, Reverter JC, de la Red G, Gil V, et al. Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies. Ann Rheum Dis 2004; 63: 730-6.

7. Finsterer J. MELAS syndrome as a differential diagnosis of ischemic stroke. Fortschr Neurol Psychiatr 2009; 77: 25-31.

8. Finsterer J. Hematological manifestations of primary mitochondrial disorders. Acta Haematol 2007; 118: 88-98.

9. Thomas C, Thomas L. Anemia of chronic disease: patho physiology and laboratory diagnosis. Lab Hematol 2005; 11: 14-23.

10. Bykhovskaya Y, Casas K, Mengesha E, Inbal A, Fischel-Ghodsian N. Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). Am J Hum Genet 2004; 74: 1303-8.

11. Dan K. Thrombocytosis in iron deficiency anemia. Intern Med 2005; 44: 1025-6.

12. Rubio-Gozalbo ME, Sengers RC, Trijbels JM, Doesburg WH, Janssen AJ, Verbeek AL, Smeitink JA. A prognostic index as diagnostic strategy in children suspected of mitochondriocytopathy. Neuropediatrics 2000; 31: 114-21.